VectaBio

Ironwood spies new frontier for $1B GLP-2 analog in exploratory phase 2 rare disease trial
Fierce Biotech
Thu, 03/28/24 - 11:16 am
Ironwood Pharmaceuticals
apraglutide
VectaBio
graft vs host disease